https://www.genomics.com https://www.genomics.com/solutions/for-partners https://www.genomics.com/solutions/for-employers https://www.genomics.com/solutions/for-healthcare https://www.genomics.com/newsroom https://www.genomics.com/about/story https://www.genomics.com/about/values https://www.genomics.com/about/team https://www.genomics.com/about/faqs https://www.genomics.com/contact https://www.genomics.com/privacy-policy https://www.genomics.com/terms-of-use https://www.genomics.com/solutions/for-individuals https://www.genomics.com/careers https://www.genomics.com/nhs https://www.genomics.com/solutions/life-sciences https://www.genomics.com/solutions/health-insights-uk https://www.genomics.com/resources/webinars/target-discovery-validation https://www.genomics.com/resources/recordings/the-genome-and-beyond-advancing-drug-discovery-and-development https://www.genomics.com/newsroom/adding-genetics-to-health-checks-improves-identification-of-people-at-risk-for-cvd https://www.genomics.com/newsroom/aha-2025-new-study-from-genomics-shows-polygenic-risk-scores-improve-the-accuracy-of-cardiovascular-disease-risk-prediction https://www.genomics.com/newsroom/american-college-of-medical-genetics-and-genomics-acmg-clinical-genetics-meeting-genomics-presents-new-research-highlighting-underdiagnosis-of-rare-genetic-disorders https://www.genomics.com/newsroom/are-genetic-tests-useful-to-predict-cancer https://www.genomics.com/newsroom/ashg-2024-new-study-from-genomics-indicates-individuals-who-have-a-genetic-predisposition-for-high-bmi-may-require-tailored-approaches-to-tackle-obesity https://www.genomics.com/newsroom/beyond-the-genome-advancing-drug-discovery-and-development https://www.genomics.com/newsroom/cambridge-office-opens https://www.genomics.com/newsroom/enrolment-has-closed-in-our-nhs-heart-study https://www.genomics.com/newsroom/genes-in-8-of-population-found-to-raise-heart-disease-risk https://www.genomics.com/newsroom/genetic-risk-testing---policyholder-misconceptions-and-benefits-to-insurers https://www.genomics.com/newsroom/genome-wide-association-study-of-14-000-cases-of-seven-common-diseases-and-3-000-shared-controls https://www.genomics.com/newsroom/genomics-and-gsk-establish-precision-medicine-collaboration-to-assess-polygenic-risk-scores-in-clinical-trial-design https://www.genomics.com/newsroom/genomics-and-novo-nordisk-partner-to-tackle-obesity---covered-in-the-telegraph https://www.genomics.com/newsroom/genomics-and-vertex-collaborate-to-identify-target-therapeutic-pathways-2 https://www.genomics.com/newsroom/genomics-announces-david-thornton-as-president https://www.genomics.com/newsroom/genomics-announces-new-extension-and-expansion-of-drug-discovery-collaboration-with-vertex https://www.genomics.com/newsroom/genomics-announces-next-stage-of-global-roll-out-of-its-predictive-clinical-tool-health-insights https://www.genomics.com/newsroom/genomics-big-data-and-machine-learning https://www.genomics.com/newsroom/genomics-features-as-one-of-newsweeks-most-loved-uk-workplaces https://www.genomics.com/newsroom/genomics-identifies-increased-levels-of-undetected-risk-of-heart-disease-in-uk-population https://www.genomics.com/newsroom/genomics-in-endpoints-news-supporting-drug-discovery-and-development https://www.genomics.com/newsroom/genomics-in-the-ipaper-people-in-their-20s-might-soon-get-statins https://www.genomics.com/newsroom/genomics-in-the-sunday-times-100-tech-2025-one-of-britains-fastest-growing-private-tech-companies https://www.genomics.com/newsroom/genomics-in-the-times-how-digital-healthcare-can-help-win-the-global-battle-with-obesity https://www.genomics.com/newsroom/genomics-is-a-best-place-to-work-sunday-times-2025 https://www.genomics.com/newsroom/genomics-ltd-completes-a-ps10-3m-fundraising https://www.genomics.com/newsroom/genomics-mystra-ai-enabled-human-genetics-platform https://www.genomics.com/newsroom/genomics-on-bbc-news https://www.genomics.com/newsroom/genomics-partnership-with-bupa-in-the-times https://www.genomics.com/newsroom/genomics-plc-analysis-demonstrates-potential-for-genomic-data-to-identify-those-most-at-risk-for-16-common-diseases https://www.genomics.com/newsroom/genomics-plc-analysis-featured-in-matt-hancock-speech https://www.genomics.com/newsroom/genomics-plc-announces-extension-of-drug-discovery-collaboration-with-vertex https://www.genomics.com/newsroom/genomics-plc-announces-genetic-risk-scoring-partnership-with-our-future-health-to-test-new-personalised-disease-prevention-approaches https://www.genomics.com/newsroom/genomics-plc-announces-publication-of-article-showing-improved-risk-prediction-for-cardiovascular-disease-across-ethnicities https://www.genomics.com/newsroom/genomics-plc-announces-successful-world-first-pilot-using-improved-genomic-risk-assessment-in-cardiovascular-disease-prevention-in-the-nhs https://www.genomics.com/newsroom/genomics-plc-announces-that-simon-dingemans-has-joined-its-board-as-the-new-chair https://www.genomics.com/newsroom/genomics-plc-bolsters-executive-leadership-team-with-two-new-hires https://www.genomics.com/newsroom/genomics-plc-ceo-awarded-knighthood https://www.genomics.com/newsroom/genomics-plc-ceo-peter-donnelly-on-panel-at-no-10-launch-event-for-uk-life-sciences-sector-deal https://www.genomics.com/newsroom/genomics-plc-collaborates-with-biogen https://www.genomics.com/newsroom/genomics-plc-collaborates-with-eisai https://www.genomics.com/newsroom/genomics-plc-completes-oversubscribed-30m-funding-round https://www.genomics.com/newsroom/genomics-plc-contributes-to-large-drug-target-validation-study-published-in-nature-communications https://www.genomics.com/newsroom/genomics-plc-discusses-funding-round-in-the-telegraph https://www.genomics.com/newsroom/genomics-plc-discusses-genomic-prevention-in-the-times https://www.genomics.com/newsroom/genomics-plc-featured-as-one-of-the-u-k-genomics-startups-changing-the-future-of-healthcare-forever-in-forbes https://www.genomics.com/newsroom/genomics-plc-founder-and-ceo-sir-peter-donnelly-awarded-royal-society-gabor-medal https://www.genomics.com/newsroom/genomics-plc-founder-sir-peter-donnelly-discusses-dna-trials-in-the-evening-standard https://www.genomics.com/newsroom/genomics-plc-grows-its-senior-management-team https://www.genomics.com/newsroom/genomics-plc-identifies-increased-levels-of-undetected-risk-of-heart-disease-in-uk-population https://www.genomics.com/newsroom/genomics-plc-publishes-results-of-nhs-trial-in-european-journal-of-preventive-cardiology https://www.genomics.com/newsroom/genomics-plc-raises-ps25-million-in-series-b-round-to-advance-its-use-of-human-genetics-and-data-science-in-drug-discovery https://www.genomics.com/newsroom/genomics-plc-selected-as-one-of-bloombergs-25-uk-startups-to-watch https://www.genomics.com/newsroom/genomics-plc-teams-up-with-biogen-to-discover-new-drug-targets-for-multiple-sclerosis https://www.genomics.com/newsroom/genomics-plc-today-announces-second-close-of-its-series-b-financing-raising-a-further-ps8-million-bringing-the-total-round-to-ps33-million https://www.genomics.com/newsroom/genomics-plc-welcomes-paper-in-nature-journal-heralding-the-power-of-genetics-in-health-research https://www.genomics.com/newsroom/genomics-plcs-approach-to-safety-regulations-standards-and-requirements https://www.genomics.com/newsroom/genomics-plcs-integrated-risk-tool-substantially-improves-coronary-artery-disease-prediction https://www.genomics.com/newsroom/genomics-profiled-in-the-times https://www.genomics.com/newsroom/genomics-raises-ps35-million-for-advanced-genetic-testing https://www.genomics.com/newsroom/genomics-recognised-as-top-drug-discovery-and-development-solutions-provider-2025 https://www.genomics.com/newsroom/genomics-releases-new-research-showing-significant-link-between-genetic-risk-and-obesity https://www.genomics.com/newsroom/genomics-welcomes-the-new-genomic-population-health-management-service-announced-in-the-governments-nhs-10-year-plan https://www.genomics.com/newsroom/genomics-wins-sbri-award https://www.genomics.com/newsroom/genomics-work-on-obesity-in-the-telegraph https://www.genomics.com/newsroom/genomics-work-on-preventing-premature-mortality-in-the-financial-times https://www.genomics.com/newsroom/greywolf-therapeutics-and-genomics-launch-strategic-relationship-to-develop-first-in-class-treatments-for-autoimmune-diseases https://www.genomics.com/newsroom/health-secretary-wants-nhs-to-roll-out-genetic-tests-to-detect-diseases https://www.genomics.com/newsroom/independent-review-of-adult-screening-programmes-notes-potential-for-polygenic-risk-scores https://www.genomics.com/newsroom/innovate-uk-success-story https://www.genomics.com/newsroom/international-womens-day-celebrating-progress-and-looking-ahead https://www.genomics.com/newsroom/jc-board-member-new https://www.genomics.com/newsroom/making-invisible-risk-visible https://www.genomics.com/newsroom/making-the-impossible-possible https://www.genomics.com/newsroom/making-the-theoretical-practical https://www.genomics.com/newsroom/making-the-universal-personal https://www.genomics.com/newsroom/maths-professor-peter-donnelly-is-set-to-save-big-pharma-billions-of-dollars https://www.genomics.com/newsroom/minister-for-health-innovation-dr-zubir-ahmed-mp-and-executive-chair-for-the-office-of-life-sciences-steve-bates-obe-open-genomics-flagship-office-in-londons-knowledge-quarter-as-it-unveils-agentic-ai-capabilities-within-mystra-drug-discovery-platform https://www.genomics.com/newsroom/mitchell-harris-joins-genomics-plc-as-chief-strategy-officer https://www.genomics.com/newsroom/new-and-improved-polygenic-risk-scores-for-28-common-diseases https://www.genomics.com/newsroom/new-paper-highlights-genomics-plc-contribution-to-collaborative-analysis-of-nanopore-sequenced-human-genomes https://www.genomics.com/newsroom/nhs-launches-new-polygenic-scores-trial-for-heart-disease https://www.genomics.com/newsroom/nhs-pilots-genetic-testing-to-predict-risk-of-heart-disease https://www.genomics.com/newsroom/our-ceo-peter-donnelly-speaks-with-john-pienaar-at-the-times-radio https://www.genomics.com/newsroom/our-response-to-aha-statement-on-polygenic-risk-scores https://www.genomics.com/newsroom/peter-donnelly-featured-on-bio-eats-world-by-a16z https://www.genomics.com/newsroom/peter-donnelly-featured-on-thermo-fisher-science-spotlight https://www.genomics.com/newsroom/peter-donnelly-features-on-bbc-world-news-impact-programme https://www.genomics.com/newsroom/polygenic-risk-scores https://www.genomics.com/newsroom/professor-gil-mcvean-elected-a-fellow-of-the-royal-society https://www.genomics.com/newsroom/professor-peter-donnelly-talks-to-bbc-world-news https://www.genomics.com/newsroom/sir-peter-donnelly-gives-plenary-keynote-at-elrig-research-innovation-2021 https://www.genomics.com/newsroom/the-fine-scale-genetic-structure-of-the-british-population https://www.genomics.com/newsroom/the-uk-biobank-resource-with-deep-phenotyping-and-genomic-data https://www.genomics.com/newsroom/vertex-and-genomics-plc-announce-multi-year-collaboration-to-use-human-genetics-and-data-science-to-identify-novel-targets-for-innovative-medicines https://www.genomics.com/newsroom/why-health-systems-are-buying-into-genomics